Clinical Trial Update: Study on the Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics of PA9159 Nasal Spray in healthy adult subjects, studied in the context of alle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• PA9159 Nasal Spray

Snippet

Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. | Conditions: Allergic Rhinitis | Phase 1 | Status: COMPLETED